Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 26, 2016 12:00 ET | Source: RAPT Therapeutics, Inc.

FLX Bio Announces $50 Million Series B Financing

SOUTH SAN FRANCISCO, Calif., April 26, 2016 (GLOBE NEWSWIRE) -- FLX Bio, Inc., a biopharmaceutical company focused on the discovery and development of novel cancer immunotherapies, announced a $50...
April 05, 2016 11:00 ET | Source: RAPT Therapeutics, Inc.

FLX Bio Completes Leadership Team in Immuno-Oncology Drug Discovery

SOUTH SAN FRANCISCO, Calif., April 05, 2016 (GLOBE NEWSWIRE) -- FLX Bio, Inc., a biopharmaceutical company focused on the discovery and development of novel cancer immunotherapies, announced today...
February 08, 2016 11:00 ET | Source: RAPT Therapeutics, Inc.

FLX Bio Hires Senior Leaders in Immuno-Oncology Drug Discovery

SOUTH SAN FRANCISCO, Calif., Feb. 08, 2016 (GLOBE NEWSWIRE) -- FLX Bio, Inc., a biopharmaceutical company focused on the discovery and development of novel cancer immunotherapies, announced...